417 related articles for article (PubMed ID: 32710244)
1. Lesion stage-dependent causes for impaired remyelination in MS.
Heß K; Starost L; Kieran NW; Thomas C; Vincenten MCJ; Antel J; Martino G; Huitinga I; Healy L; Kuhlmann T
Acta Neuropathol; 2020 Sep; 140(3):359-375. PubMed ID: 32710244
[TBL] [Abstract][Full Text] [Related]
2. Extrinsic immune cell-derived, but not intrinsic oligodendroglial factors contribute to oligodendroglial differentiation block in multiple sclerosis.
Starost L; Lindner M; Herold M; Xu YKT; Drexler HCA; Heß K; Ehrlich M; Ottoboni L; Ruffini F; Stehling M; Röpke A; Thomas C; Schöler HR; Antel J; Winkler J; Martino G; Klotz L; Kuhlmann T
Acta Neuropathol; 2020 Nov; 140(5):715-736. PubMed ID: 32894330
[TBL] [Abstract][Full Text] [Related]
3. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
[TBL] [Abstract][Full Text] [Related]
4. Limited TCF7L2 expression in MS lesions.
Lürbke A; Hagemeier K; Cui QL; Metz I; Brück W; Antel J; Kuhlmann T
PLoS One; 2013; 8(8):e72822. PubMed ID: 23977356
[TBL] [Abstract][Full Text] [Related]
5. Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.
Marro BS; Skinner DD; Cheng Y; Grist JJ; Dickey LL; Eckman E; Stone C; Liu L; Ransohoff RM; Lane TE
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243125
[TBL] [Abstract][Full Text] [Related]
6. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
[TBL] [Abstract][Full Text] [Related]
7. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
8. p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
Marziali LN; Hwang Y; Palmisano M; Cuenda A; Sim FJ; Gonzalez A; Volsko C; Dutta R; Trapp BD; Wrabetz L; Feltri ML
Brain; 2024 May; 147(5):1871-1886. PubMed ID: 38128553
[TBL] [Abstract][Full Text] [Related]
9. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
Tepavčević V; Lubetzki C
Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
[TBL] [Abstract][Full Text] [Related]
11. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis.
Kuhlmann T; Miron V; Cui Q; Wegner C; Antel J; Brück W
Brain; 2008 Jul; 131(Pt 7):1749-58. PubMed ID: 18515322
[TBL] [Abstract][Full Text] [Related]
12. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
13. Oligodendrocytes and Microglia: Key Players in Myelin Development, Damage and Repair.
Kalafatakis I; Karagogeos D
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356682
[TBL] [Abstract][Full Text] [Related]
14. Cells of the oligodendroglial lineage, myelination, and remyelination.
Miron VE; Kuhlmann T; Antel JP
Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
[TBL] [Abstract][Full Text] [Related]
15. The K
Albrecht S; Korr S; Nowack L; Narayanan V; Starost L; Stortz F; Araúzo-Bravo MJ; Meuth SG; Kuhlmann T; Hundehege P
Glia; 2019 May; 67(5):870-883. PubMed ID: 30623969
[TBL] [Abstract][Full Text] [Related]
16. MMP7 cleaves remyelination-impairing fibronectin aggregates and its expression is reduced in chronic multiple sclerosis lesions.
Wang P; Gorter RP; de Jonge JC; Nazmuddin M; Zhao C; Amor S; Hoekstra D; Baron W
Glia; 2018 Aug; 66(8):1625-1643. PubMed ID: 29600597
[TBL] [Abstract][Full Text] [Related]
17. Activation of oligodendroglial Stat3 is required for efficient remyelination.
Steelman AJ; Zhou Y; Koito H; Kim S; Payne HR; Lu QR; Li J
Neurobiol Dis; 2016 Jul; 91():336-46. PubMed ID: 27060559
[TBL] [Abstract][Full Text] [Related]
18. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions.
Fard MK; van der Meer F; Sánchez P; Cantuti-Castelvetri L; Mandad S; Jäkel S; Fornasiero EF; Schmitt S; Ehrlich M; Starost L; Kuhlmann T; Sergiou C; Schultz V; Wrzos C; Brück W; Urlaub H; Dimou L; Stadelmann C; Simons M
Sci Transl Med; 2017 Dec; 9(419):. PubMed ID: 29212715
[TBL] [Abstract][Full Text] [Related]
19. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
[TBL] [Abstract][Full Text] [Related]
20. Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis.
Motavaf M; Sadeghizadeh M; Javan M
Cell Mol Neurobiol; 2017 Nov; 37(8):1335-1348. PubMed ID: 28224237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
